Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Assets Average (2016 - 2025)

Historic Assets Average for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $205.0 million.

  • Marimed's Assets Average fell 266.92% to $205.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.0 million, marking a year-over-year decrease of 266.92%. This contributed to the annual value of $201.6 million for FY2024, which is 1572.87% up from last year.
  • As of Q3 2025, Marimed's Assets Average stood at $205.0 million, which was down 266.92% from $206.2 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Assets Average registered a high of $210.6 million during Q3 2024, and its lowest value of $83.2 million during Q1 2021.
  • Over the past 5 years, Marimed's median Assets Average value was $186.9 million (recorded in 2023), while the average stood at $165.7 million.
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 6215.51% in 2021, then crashed by 266.92% in 2025.
  • Over the past 5 years, Marimed's Assets Average (Quarter) stood at $120.7 million in 2021, then rose by 22.97% to $148.4 million in 2022, then surged by 30.33% to $193.5 million in 2023, then increased by 8.46% to $209.8 million in 2024, then fell by 2.31% to $205.0 million in 2025.
  • Its last three reported values are $205.0 million in Q3 2025, $206.2 million for Q2 2025, and $207.5 million during Q1 2025.